Chris Murphy actually said...

these agreements that have been negotiated under this administration have done more to open the door toward these types of activities than I...

It took us a long time to educate both providers and patients about chemical generics.

We talked about the certainty that the industry needs to start populating the field with more biosimilars.

I know this is an issue that doesn't necessarily fit natural to Congress to be funding physician and provider education, but we're talking a...